Understanding fibromyalgia pathophysiology
Fibromyalgia affects approximately 2–4% of the population, predominantly women. Its defining features:
- Central sensitisation: The pain-processing centres of the brain and spinal cord amplify pain signals — the same stimulus that produces mild discomfort in healthy people generates intense pain in fibromyalgia
- Mitochondrial dysfunction: Multiple studies show reduced mitochondrial ATP production in fibromyalgia patients, corresponding with their characteristic fatigue and post-exertional malaise
- Oxidative stress: Elevated markers of oxidative stress (elevated MDA, reduced glutathione, lower SOD activity) are consistently documented — thought to contribute to both pain sensitisation and mitochondrial dysfunction
- Sleep disruption: Non-restorative sleep (alpha wave intrusion into delta sleep stages) is nearly universal — and poor sleep worsens pain amplification in a bidirectional cycle
- Mild systemic inflammation: Some studies show elevated CRP and IL-6, but the inflammatory component is less prominent than in rheumatoid arthritis — the neurological central sensitisation component dominates
Where spirulina’s mechanisms are relevant
Mitochondrial oxidative stress: the strongest case
Phycocyanobilin inhibits NADPH oxidase — the primary enzyme producing mitochondrial superoxide. This directly addresses the mitochondrial ROS elevation documented in fibromyalgia.
Additionally, Nrf2 activation (by phycocyanobilin) upregulates endogenous antioxidant enzymes including SOD, catalase, and glutathione synthase — addressing the glutathione depletion consistently found in fibromyalgia patients.
A small (n=20) Brazilian pilot study (Selmi et al., 2011) found spirulina supplementation at 6 g/day for 8 weeks reduced fatigue scores and improved antioxidant markers in fibromyalgia patients. This is a single, small, industry- funded study — it warrants replication, but the direction aligns with the mechanistic prediction.
B vitamins for energy metabolism
Spirulina provides riboflavin (B2), thiamine (B1), niacin (B3), and B6 — all required for mitochondrial energy metabolism. B vitamin insufficiency can worsen mitochondrial dysfunction; spirulina contributes to ensuring cofactor adequacy.
Importantly, spirulina does not provide B12 in active form — and B12 deficiency impairs mitochondrial function through the methylation cycle. Fibromyalgia patients, particularly older women who are the primary affected group, should test B12 and supplement separately if low.
Iron and fatigue
Iron deficiency anaemia and sub-clinical iron deficiency (low ferritin without anaemia) produce fatigue symptoms that can amplify or mimic fibromyalgia fatigue. Before attributing fatigue entirely to fibromyalgia, ferritin testing is essential.
Studies in fibromyalgia patients show higher prevalence of iron deficiency than matched controls. Spirulina’s iron is meaningful if iron deficiency is contributing to the fatigue burden.
Sleep: tryptophan and magnesium pathways
Non-restorative sleep is both a symptom and a driver of fibromyalgia. Spirulina contains tryptophan (the serotonin and melatonin precursor pathway) and magnesium (required for GABA receptor function and sleep quality).
These are food-level contributions — not equivalent to dedicated melatonin supplementation or sleep medications. But for people with fibromyalgia managing multiple symptom domains, nutritional foundations for sleep are clinically relevant.
Where spirulina is less relevant
Because central sensitisation is the dominant mechanism in fibromyalgia, spirulina’s:
- Peripheral anti-inflammatory effects (COX-2, NF-κB inhibition): Less directly relevant than they are for, say, rheumatoid arthritis — the pain in fibromyalgia is centrally amplified, not primarily driven by peripheral tissue inflammation
- Iron for pain:Iron deficiency can worsen pain sensitivity (iron is required for dopaminergic transmission), but correcting iron to normal doesn’t resolve fibromyalgia pain
Evidence summary
| Spirulina mechanism | Fibromyalgia relevance | Evidence grade |
|---|---|---|
| Phycocyanobilin / NADPH oxidase inhibition | High — addresses mitochondrial oxidative stress directly | Mechanistic + 1 small pilot trial |
| Nrf2 / glutathione upregulation | High — glutathione depletion is a documented feature | Mechanistic (animal models) |
| Iron for fatigue | Relevant if iron-deficient (test first) | Established in iron deficiency literature |
| B vitamins for mitochondrial function | Moderate — cofactor adequacy support | Indirect |
| Tryptophan / magnesium for sleep | Moderate — food-level contributions | Mechanistic |
| COX-2 / peripheral inflammation | Low — not primary fibromyalgia mechanism | Established for other inflammatory conditions |
Practical guidance
- Test before supplementing: Ferritin, B12, and vitamin D — these nutritional deficiencies should be corrected first as they each independently worsen fibromyalgia symptoms.
- Dose: 6 g/day is the dose used in the Selmi pilot trial showing fatigue benefit. This provides approximately 480–900 mg phycocyanin depending on product quality.
- Prioritise quality: For the phycocyanin mechanism to be effective, choose spirulina with documented phycocyanin content (CoA). Low-phycocyanin commodity spirulina may not provide enough phycocyanobilin.
- Concurrent strategies: The best-evidenced fibromyalgia interventions remain aerobic exercise, CBT, and duloxetine/pregabalin. Spirulina is a nutritional adjunct, not an alternative.